Open AccessA phase I trial of sorafenib combined with cisplatin/etoposide or carboplatin/pemetrexed in refractory solid tumor patients
Author(s) -
Janine M. Davies,
Nirav Dhruva,
Christine M. Walko,
Mark A. Socinski,
Stephen A. Bernard,
D. Neil Hayes,
William Y. Kim,
Anastasia Ivanova,
Kimberly L. Keller,
Layla R. Hilbun,
Michael H. Chiu,
E. Claire Dees,
Thomas E. Stinchcombe
Publication year - 2011
Publication title -
carolina digital repository (university of north carolina at chapel hill)
Language(s) - English
DOI - 10.17615/wwdz-qn58
Subject(s) - carboplatin , pemetrexed , cisplatin , sorafenib , etoposide , oncology , medicine , refractory (planetary science) , cancer research , chemotherapy , materials science , hepatocellular carcinoma , composite material
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom